Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

Clinical trial NCT07203664 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07203664
Sponsor: Hospital Universitario La Paz
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients

Start date: 2025-10-30
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.